https://medicaldialogues.in/cardiology-ctvs/news/adalimumab-use-in-ra-not-linked-to-increased-mace-and-vte-compared-to-jak-inhibitors-100776
0
0
33 words
0
Comments
Researchers have found in a new study that risks for major adverse cardiac events and venous...
You are the first to view
Create an account or login to join the discussion